Abstract: The invention relates to an electrically insulating test cap for a high-voltage contact, comprising a base body, at least one test opening piercing the base body, wherein a tubular sheathing encloses the test opening and leads away from the base body in a longitudinal direction of the sheathing. Further, the invention relates to a housing for a high voltage box comprising a housing wall, a test cap according to the invention, wherein the test cap extends through the housing wall into the interior of the housing. Furthermore, the invention relates to a high-voltage box comprising a housing according to the invention or an outer wall accommodating an electrically insulating test cap and a high-voltage board with a test contact arranged at the level of the test cap.

Abstract: An electrical connector configured to be mated to a mating connector includes a housing assembly and a core assembly held rotatably within the housing assembly. The core assembly includes a contact assembly having a contact configured to electrically contact a mating contact of the mating connector, a finger protection assembly configured to at least partially cover the contact assembly, and a cable retention assembly configured to be attached onto an electrical cable.

Abstract: A crimp assembly for electrically contacting a conductive component of an electrical cable includes an anvil bushing and a compression sleeve. The anvil bushing has a retention shoulder extending circumferentially on an outer peripheral surface of the anvil bushing and supporting a section of the conductive component. The compression sleeve has an inner diameter larger than an outer diameter of the retention shoulder.

Abstract: An electrical connector configured to be mated to a mating connector includes a housing assembly and a core assembly held rotatably within the housing assembly. The core assembly includes a contact assembly having a contact configured to electrically contact a mating contact of the mating connector, a finger protection assembly configured to at least partially cover the contact assembly, and a cable retention assembly configured to be attached onto an electrical cable.

Abstract: A module for a high-current plug and/or a high-current cable includes a coupling face coupling to a shield and an influencing device influencing an electromagnetic property of the shield.

Abstract: A crimp assembly for electrically contacting a conductive component of an electrical cable includes an anvil bushing and a compression sleeve. The anvil bushing has a retention shoulder extending circumferentially on an outer peripheral surface of the anvil bushing and supporting a section of the conductive component. The compression sleeve has an inner diameter larger than an outer diameter of the retention shoulder.

Abstract: A module for a high-current plug and/or a high-current cable includes a coupling face coupling to a shield and an influencing device influencing an electromagnetic property of the shield.

Abstract: Disclosed are substituted quinolines of formula 1 wherein R1 and R2 are defined herein, the processing of making and using the same.

Abstract: Disclosed are substituted quinolines of formula 1 wherein R1 and R2 are defined herein, the processing of making and using the same.

Abstract: This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, Ar, R1, R2, R3 have meanings given in the description.

Abstract: Disclosed are substituted quinolines of formula 1 wherein R1 and R2 are defined herein, the processing of making and using the same.

Abstract: This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, Ar, R1, R2, R3 have meanings given in the description.

Abstract: This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, Ar, R1, R2, R3, R3a have meanings given in the description.

Abstract: This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, Ar, R1, R2, R3 have meanings given in the description.

Abstract: This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, X, R1, R2, R3 have meanings given in the description.

Abstract: This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, X, R1, R2, R3 have meanings given in the description.

Abstract: This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, X, R1, R2, R3 have meanings given in the description.

Abstract: This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, X, R1, R2, R3 have meanings given in the description.

Abstract: This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, Ar, R1, R2, R3 have meanings given in the description.

Abstract: This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, X, R1, R2, R3 have meanings given in the description.